Co-Chair: Morie A. Gertz, MD, MACP (he/him/his) – Mayo Clinic
Co-Chair: Hartmut Goldschmidt, MD – Department of Medicine V, University Hospital Heidelberg; and National Center for Tumor Diseases (NCT)
Co-Chair: Annemiek Broijl, MD, PhD (she/her/hers) – ErasmusMC
Co-Chair: Lugui Qiu, MD (he/him/his) – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.
Speaker: Camila Guerrero – Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369
Speaker: Elizabeth D. Lightbody, PhD – Dana-Farber Cancer Institute
Speaker: Afsaneh Panahi, MSc – BC Cancer Research Centre/ University of British Columbia
Speaker: Annika Werly – Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
Speaker: Charan T R Vegivinti, MD (he/him/his) – Jacobi Medical Center / Albert Einstein College of Medicine
Speaker: wei tan, Ph.D – The University of Texas MD Anderson Cancer Center
Speaker: Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine
Speaker: Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
Speaker: Hao Mu, Principle Investigation (she/her/hers) – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Speaker: Albert Oriol, PhD (he/him/his) – Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
Co-Chair: Gordon Cook, PhD – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK
Co-Chair: Eirini Katodritou, MD, PhD (she/her/hers) – Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece
Co-Chair: Masood A. Shammas, PhD – Dana Farber Cancer Institute and VA Boston Healthcare System, Boston, MA, USA
Co-Chair: Mark Bustoros, MD – Meyer Cancer Center, Weill Cornell Medicine, Cornell University
Speaker: Kylee Maclachlan, MBChB, PhD – Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City NY, USA
Speaker: Darrell White, MD (he/him/his) – Dalhousie University and Queen Elizabeth II Health Sciences Centre
Speaker: Linda B. Baughn, PhD (she/her/hers) – Mayo Clinic, Rochester, MN, US
Speaker: Jonathan L. Kaufman, MD – Winship Cancer Institute of Emory University
Speaker: Meral Beksac, MD (she/her/hers) – Ankara University
Speaker: Jiye Liu, PhD (he/him/his) – Dana-Farber Cancer Institute
Speaker: Takahiro Kamiya, MD (he/him/his) – Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan / Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
Speaker: Samer Al Hadidi, MD,MS,FACP – the University of Arkansas for Medical Sciences
Speaker: Jian Cui – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College
Speaker: Cyrille Touzeau, MD, PhD – CHU Nantes
Co-Chair: Robert Z. Orlowski, PhD, MD (he/him/his) – The University of Texas MD Anderson Cancer Center
Co-Chair: Qing Yi, MD, PhD (he/him/his) – Houston Methodist Neal Cancer Center
Speaker: Alejandro Medina-Herrera, PhD – Departamento de Hematología, Hospital Universitario de Salamanca, (HUSA/IBSAL), Centro de Investigación del Cáncer-IBMCC (CSIC/USAL), CIBERONC
Speaker: Samir Parekh, MD – Mount Sinai Medical Center, New York, NY, USA
Speaker: Parvathi Sudha, MS (she/her/hers) – Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA
Speaker: Paola Neri, MD PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary
Speaker: Carlos Fernandez de Larrea, MD, PhD – Hospital Clínic de Barcelona
Speaker: Tom Martin, MD (he/him/his) – UCSF
Speaker: Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France
Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
Speaker: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca
Speaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
Speaker: Noemi Puig, MD, PhD – Hospital Universitario de Salamanca, Instituto de investigación biomédica de Salamanca (IBSAL)
Speaker: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Co-Chair: Katja Weisel, MD (she/her/hers) – University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
Co-Chair: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre
Co-Chair: Eileen M. Boyle, MD PhD – UCL Cancer Institute
Co-Chair: Fanghuang Zhan, MD & PhD (he/him/his) – University of Arkasas Medical Sciences
Speaker: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre
Speaker: Brian A. Walker, PhD (he/him/his) – Indiana University
Speaker: Jessica Encinas Mayoral (she/her/hers) – Fundación Investigación Biomédica Hospital 12 de Octubre
Speaker: Shonali Midha, MD – Dana Farber Cancer Institute
Speaker: Aintzane Zabaleta, PhD (she/her/hers) – CIMA (Pamplona)
Speaker: Salomon Manier, MD, PhD – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France
Speaker: Jieyun Xia, MD – The Affiliated Hospital of Xuzhou Medical University
Speaker: Jian Cui – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College
Speaker: Ross S. Firestone, MD/PhD (he/him/his) – Memorial Sloan Kettering Cancer Center, New York City NY, USA
Speaker: Eyal Lebel, MD – Hadassah medical center